Farms.com Home   News

Biofuels Industry Seeks Inclusion of Eethanol in Carbon Reduction Plans

The biofuels industry is casting doubt on the idea liquid fuel will be phased out anytime soon, but it’s also lobbying for ethanol and biodiesel to be included in carbon reduction plans.

President Biden was joined by Ford and GM executives yesterday as he announced a set of fuel efficiency standards, with the goal of having up to half of the vehicles sold in the U.S. be electric by 2030. Iowa Renewable Fuels Association executive director Monte Shaw refers to those kind of goals as aspirational.

“They aren’t all going to be purely EVs — electric vehicles,” Shaw said last weekend on “Iowa Press” on Iowa PBS. “Some of them will be what are called hybrid, where they still do have a liquid-powered engine and no one you talk to thinks it can happen that fast.”

Shaw suggested a vehicle in Iowa that’s burning gas with 85% ethanol today likely has a lower carbon footprint than an electric vehicle, because 25% of the electricity in Iowa is generated from coal.

“The corn plant sucks carbon out of the air,” Shaw said. “An EV doesn’t do that so we actually have a pathway where in the next 10 years we think we can get…actually net negative carbon fuel.”

Kelly Niewenhaus, a farmer from Primghar who is on the Iowa Corn Promotion Board, said the other obstacle is there’s no nationwide grid to support electric vehicles.

“We’ve got the infrastructure today for more biofuels and to clean up our environment today and lower our greenhouse gas emissions and be the solution for climate change, so why not do that?” Niewenhaus asked.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.